Inventor · disambiguated record
Bruce Keyt
Also filed as: KEYT BRUCE · KEYT BRUCE A · KEYT BRUCE ALAN
55 granted patents·34 pending applications·995 citations·filing 1992–2023
99Inventor score
Top patents by PatentIndex Score
89 records- 0198US10975147B2Modified J-chainIGM BIOSCIENCES INC·Filed 2020·Granted Apr 13, 2021·8 cites·28 claims
- 0298US10400038B2Modified J-chainIGM BIOSCIENCES INC·Filed 2015·Granted Sep 3, 2019·21 cites·21 claims
- 0398US9951134B2Modified J-chainIGM BIOSCIENCES INC·Filed 2017·Granted Apr 24, 2018·25 cites·23 claims
- 0497US11542342B2Binding molecules with modified J-chainIGM BIOSCIENCES INC·Filed 2020·Granted Jan 3, 2023·4 cites·27 claims
- 0597US11192941B2Multi-valent human immunodeficiency virus antigen binding molecules and uses thereofIGM BIOSCIENCES INC·Filed 2020·Granted Dec 7, 2021·4 cites·20 claims
- 0697US10618978B2Binding molecules with modified J-chainIGM BIOSCIENCES INC·Filed 2016·Granted Apr 14, 2020·16 cites·7 claims
- 0797US7736644B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofAMGEN FREMONT INC·Filed 2004·Granted Jun 15, 2010·77 cites·115 claims
- 0897US7628986B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofAMGEN FREMONT INC·Filed 2004·Granted Dec 8, 2009·119 cites·83 claims
- 0996US10954302B2Anti-PD-L1 antibodiesIGM BIOSCIENCES INC·Filed 2017·Granted Mar 23, 2021·10 cites·19 claims
- 1096US10899835B2IgM Fc and J-chain mutations that affect IgM serum half-lifeIGM BIOSCIENCES INC·Filed 2020·Granted Jan 26, 2021·7 cites·28 claims
- 1195US7973140B2Antibodies directed to angiopoietin-2 and uses thereofMEDIMMUNE LTD·Filed 2005·Granted Jul 5, 2011·36 cites·11 claims
- 1295US7423128B2Anti-properdin antibodies, and methods for making and using sameAMGEN FREMONT INC·Filed 2004·Granted Sep 9, 2008·82 cites·34 claims
- 1394US10787520B2Multimeric bispecific binding molecules specific for CD20 and CD3IGM BIOSCIENCES INC·Filed 2016·Granted Sep 29, 2020·13 cites·31 claims
- 1493US10604559B2Multi-valent hepatitis B virus antigen binding molecules and uses thereofIGM BIOSCIENCES INC·Filed 2016·Granted Mar 31, 2020·15 cites·18 claims
- 1593US9096672B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2009·Granted Aug 4, 2015·16 cites·38 claims
- 1693US6057428AVariants of vascular endothelial cell growth factorGENENTECH INC·Filed 1996·Granted May 2, 2000·90 cites·20 claims
- 1792US9938347B2Tumor necrosis factor (TNF) superfamily receptor IgM antibodies and uses thereofIGM BIOSCIENCES AS·Filed 2017·Granted Apr 10, 2018·21 cites·16 claims
- 1892US6020473ANucleic acids encoding variants of vascular endothelial cell growth factorGENENTECH INC·Filed 1995·Granted Feb 1, 2000·92 cites·8 claims
- 1991US10689449B2Multimeric death domain-containing receptor-5 (DR5) antibodies and uses thereofIGM BIOSCIENCES INC·Filed 2016·Granted Jun 23, 2020·12 cites·30 claims
- 2091US10351631B2Constant chain modified bispecific, penta- and hexavalent Ig-M antibodiesIGM BIOSCIENCES INC·Filed 2014·Granted Jul 16, 2019·18 cites·22 claims
- 2190US11535664B2Multi-valent hepatitis B virus antigen binding molecules and uses thereofIGM BIOSCIENCES INC·Filed 2020·Granted Dec 27, 2022·2 cites·19 claims
- 2290US8362215B2Antibodies immunoreactive with heregulin-coupled HER3TRELLIS BIOSCIENCE LLC·Filed 2010·Granted Jan 29, 2013·9 cites·23 claims
- 2390US7736648B2Anti-RSV G protein antibodiesTRELLIS BIOSCIENCE INC·Filed 2008·Granted Jun 15, 2010·13 cites·21 claims
- 2490US7427596B2Variants of vascular endothelial cell growth factor, their uses, and processes for their productionGENENTECH INC·Filed 2005·Granted Sep 23, 2008·10 cites·19 claims
- 2589US10570191B2Multi-valent human immunodeficiency virus antigen binding molecules and uses thereofIGM BIOSCIENCES INC·Filed 2016·Granted Feb 25, 2020·7 cites·14 claims
- 2688US11639389B2Binding molecules with modified J-chainIGM BIOSCIENCES INC·Filed 2016·Granted May 2, 2023·4 cites·14 claims
- 2788US11555075B2Modified J-chainIGM BIOSCIENCES INC·Filed 2018·Granted Jan 17, 2023·2 cites·46 claims
- 2888US9409976B2CDIM binding proteins and uses thereofTENG NELSON N H·Filed 2013·Granted Aug 9, 2016·19 cites·23 claims
- 2988US9062113B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2008·Granted Jun 23, 2015·7 cites·28 claims
- 3085US7572444B2Binding proteins specific for human matriptaseAMGEN FREMONT INC·Filed 2005·Granted Aug 11, 2009·12 cites·17 claims
- 3184US8834880B2Antibodies directed to angiopoietin-2 and uses thereofMEDIMMUNE LTD·Filed 2012·Granted Sep 16, 2014·5 cites·4 claims
- 3283US11578131B2Polynucleotides encoding death domain-containing receptor-5 (DR5) binding moleculesIGM BIOSCIENCES INC·Filed 2020·Granted Feb 14, 2023·1 cites·23 claims
- 3382US9073998B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2009·Granted Jul 7, 2015·3 cites·88 claims
- 3481US12486336B2Binding molecules with modified J-chainIGM BIOSCIENCES INC·Filed 2022·Granted Dec 2, 2025·0 cites·13 claims
- 3581US11492411B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofAMGEN FREMONT INC·Filed 2019·Granted Nov 8, 2022·0 cites·20 claims
- 3681US10118968B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2009·Granted Nov 6, 2018·2 cites·54 claims
- 3781US8143447B2Treatment of cancerMOORE JEROME·Filed 2007·Granted Mar 27, 2012·4 cites·4 claims
- 3881US2023279111A1Modified j-chainIGM BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 3980US9085624B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2008·Granted Jul 21, 2015·2 cites·26 claims
- 4080US5612029ATissue plasminogen activator glycosylation variants with improved therapeutic propertiesGENENTECH INC·Filed 1995·Granted Mar 18, 1997·49 cites·2 claims
- 4180US2024002514A1Anti-pd-l1 antibodiesIGM BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 4279US10822399B2IgA multi-specific binding moleculesIGM BIOSCIENCES INC·Filed 2015·Granted Nov 3, 2020·2 cites·17 claims
- 4379US6750044B1Variants of vascular endothelial cell growth factor having antagonistic properties, nucleic acids encoding the same and host cells comprising those nucleic acidsGENENTECH INC·Filed 1996·Granted Jun 15, 2004·36 cites·16 claims
- 4479US2024124584A1Igm fc and j-chain mutations that affect igm serum half-lifeIGM BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 4578US10066011B2Antibodies directed to angiopoietin-2 and uses thereofMEDIMMUNE LTD·Filed 2014·Granted Sep 4, 2018·2 cites·15 claims
- 4678US2023203173A1Tumor necrosis factor (tnf) superfamily receptor igm antibodies and uses thereofIGM BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 4777US8273354B2Anti-RSV G protein antibodiesKAUVAR LAWRENCE M·Filed 2010·Granted Sep 25, 2012·3 cites·22 claims
- 4875US10508153B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofAMGEN FREMONT INC·Filed 2015·Granted Dec 17, 2019·1 cites·61 claims
- 4974US8828388B2Antibodies immunoreactive with heregulin-coupled HER3TRELLIS BIOSCIENCE LLC·Filed 2013·Granted Sep 9, 2014·1 cites·12 claims
- 5069US2022403009A1Multimeric coronavirus binding molecules and uses thereofIGM BIOSCIENCES INC·Filed 2022·Application pending·0 cites
Showing the top 50 of 89 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →